We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
-0.24%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$53.1B
AUM Growth
+$73M
(+0.14%)
Cap. Flow
+$888M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
11.45%
Holding
2,572
New
160
Increased
1,214
Reduced
1,013
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$552M |
| 2 |
First Trust Financials AlphaDEX Fund
FXO
|
+$539M |
| 3 |
SMAR
Smartsheet Inc.
SMAR
|
+$154M |
| 4 |
Ciena
CIEN
|
+$135M |
| 5 |
VMW
VMware, Inc
VMW
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$578M |
| 2 |
Lumen
LUMN
|
+$121M |
| 3 |
Meta Platforms (Facebook)
META
|
+$120M |
| 4 |
RTN
Raytheon Company
RTN
|
+$110M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 12.47% |
| 3 | Healthcare | 10.57% |
| 4 | Communication Services | 9.5% |
| 5 | Consumer Discretionary | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Charles River Laboratories
CRL
$10.9B
| $76.7M | 0.14% |
579,077
-347,847
| -38% | -$46.6M |
|
177
Vertex Pharmaceuticals
VRTX
$121B
| $75.6M | 0.14% |
446,434
-221,798
| -33% | -$39.2M |
|
178
CSX Corp
CSX
$98.6B
| $75.5M | 0.14% |
3,269,469
+383,625
| +13% | +$8.93M |
|
179
Eaton
ETN
$157B
| $75.4M | 0.14% |
906,922
+11,616
| +1% | +$941K |
|
180
Raymond James Financial
RJF
$32.5B
| $75M | 0.14% |
1,364,504
+205,145
| +18% | +$11.1M |
|
181
Costco
COST
$415B
| $75M | 0.14% |
260,351
+2,639
| +1% | +$743K |
|
182
Baxter International
BAX
$11.6B
| $74.9M | 0.14% |
856,428
-85,585
| -9% | -$7.31M |
|
183
Conagra Brands
CAG
$7.07B
| $74.8M | 0.14% |
2,437,567
+521,020
| +27% | +$15M |
|
184
CVS Health
CVS
$137B
| $74.3M | 0.14% |
1,177,458
-112,520
| -9% | -$6.67M |
|
185
Boston Scientific
BSX
$65.8B
| $73.5M | 0.14% |
1,806,774
+1,466,762
| +431% | +$62.1M |
|
186
Walt Disney
DIS
$165B
| $73.3M | 0.14% |
562,758
+38,100
| +7% | +$5.27M |
|
|
PS
187
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $73.3M | 0.14% |
4,363,979
+1,534,322
| +54% | +$33M |
|
188
Equitable Holdings
EQH
$13.1B
| $73.2M | 0.14% |
3,305,153
+376,244
| +13% | +$8.07M |
|
189
Hartford Financial Services
HIG
$38.5B
| $72.7M | 0.14% |
1,199,437
+150,178
| +14% | +$8.79M |
|
190
Travelers Companies
TRV
$80.8B
| $72.3M | 0.14% |
486,210
+98,033
| +25% | +$14.6M |
|
191
T-Mobile US
TMUS
$193B
| $72.1M | 0.14% |
915,421
-11,329
| -1% | -$888K |
|
192
Idacorp
IDA
$8.23B
| $71.5M | 0.13% |
634,727
+299,636
| +89% | +$31.9M |
|
193
Telephone and Data Systems
TDS
$3.91B
| $71.2M | 0.13% |
2,761,589
-58,602
| -2% | -$1.64M |
|
194
Exelixis
EXEL
$13.9B
| $71.2M | 0.13% |
4,025,206
-1,840,431
| -31% | -$37.2M |
|
195
Truist Financial
TFC
$63.2B
| $70.8M | 0.13% |
1,326,871
+129,225
| +11% | +$6.4M |
|
196
Quest Diagnostics
DGX
$25.1B
| $70.8M | 0.13% |
661,097
-29,620
| -4% | -$3.04M |
|
197
Moody's
MCO
$82.4B
| $69.6M | 0.13% |
339,981
+43,556
| +15% | +$9.13M |
|
198
Trane Technologies
TT
$106B
| $69.5M | 0.13% |
564,465
+456,072
| +421% | +$55.7M |
|
199
S&P Global
SPGI
$126B
| $68.7M | 0.13% |
280,227
+21,143
| +8% | +$5.28M |
|
200
PNC Financial Services
PNC
$100B
| $68.3M | 0.13% |
486,945
-16,440
| -3% | -$2.23M |
|
Similar funds
DAM
First Trust Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, First Trust Advisors held 2,572 positions worth $53.1B, up 0.14% from $53B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
First Trust Advisors's Q3 2019 filing shows 160 new, 1,214 increased, 1,013 reduced and 182 closed positions. Its largest new stake was First Trust Financials AlphaDEX Fund: 17,037,947 shares worth $542M. The largest sale was First Trust NYSE Arca Biotechnology Index Fund, an estimated $578M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- First Trust Advisors's largest Q3 2019 buy was First Trust Financials AlphaDEX Fund: 17,037,947 shares worth $542M.
- First Trust Advisors added most to Cisco in Q3 2019, an estimated $552M increase.
- First Trust Advisors's biggest Q3 2019 reduction was Lumen, cutting an estimated $121M.
- First Trust Advisors fully exited First Trust NYSE Arca Biotechnology Index Fund in Q3 2019, selling an estimated $578M.
- First Trust Advisors's ten largest holdings make up 11% of its $53.1B portfolio in Q3 2019.
- First Trust Advisors opened 160 new positions and closed 182 in Q3 2019.
- First Trust Advisors's portfolio value rose 0.14% quarter-over-quarter to $53.1B.
Based on First Trust Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.